|
|||||
|
|
Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib |
|
| Authors: | Jarushka Naidoo MB BCH BAO Camelia S. Sima MB MS Katherine Rodriguez BS Natalie Busby BS Khedoudja Nafa MD Marc Ladanyi MD Gregory J. Riely MD PhD Mark G. Kris MD Helena A. Yu MD |
| Affiliation: | 1. Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York;3. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York;4. Weill Cornell Medical College, New York, New York |
| Abstract: | |
| Keywords: | advanced epidermal growth factor receptor (EGFR) erlotinib exon 20 insertion lung adenocarcinoma |